| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/22/2002 | WO2000036092A9 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 08/22/2002 | WO2000034476A9 Nucleic acid molecules of shrimp |
| 08/22/2002 | WO2000033865A9 Methods of inhibiting ectopic calcification |
| 08/22/2002 | WO2000032239A9 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 08/22/2002 | WO2000026247A9 Ikaros isoforms and mutants |
| 08/22/2002 | WO2000023092A9 Contulakin-g, analogs thereof and uses therefor |
| 08/22/2002 | WO2000020449A9 MODIFIED TGF-β SUPERFAMILY PROTEINS |
| 08/22/2002 | WO2000014200A9 Essential bacterial genes and their use |
| 08/22/2002 | WO2000011195A9 C-myc is activated by beta-catenin and tcf-4 |
| 08/22/2002 | WO2000011186A9 Modified hcv peptide vaccines |
| 08/22/2002 | US20020116737 Inducing necrotic effect in preferential cells of plant; obtain plant, transform preferential cells with vector containing antiviral protein, monitor expression of antiviral protein in cells |
| 08/22/2002 | US20020116734 Plant derived bag homologues |
| 08/22/2002 | US20020116733 Generating disease resistant plant sesds; obtain seeds, incubate with hypersensitive response protein, classify plants propagated from seeds |
| 08/22/2002 | US20020116728 Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions |
| 08/22/2002 | US20020116726 Muir-torre-like syndrome in Fhit deficient mice |
| 08/22/2002 | US20020116725 Method to increase cerebral blood flow in amyloid angiopathy |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020116723 Insect expression vectors |
| 08/22/2002 | US20020115849 Plant promoter activated by fungal infection |
| 08/22/2002 | US20020115848 IBD-associated microbial nucleic acid molecules |
| 08/22/2002 | US20020115847 Nuclear receptor of given amino acid sequence; receptor modulates 9-cis retinoic acid signalling |
| 08/22/2002 | US20020115840 Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof |
| 08/22/2002 | US20020115837 Nucleoide sequences coding protein for use in human therapeutics and diagnostics |
| 08/22/2002 | US20020115834 New process for the production of biologically active protein |
| 08/22/2002 | US20020115833 Glycoprotein for use in the treatment of kidney and blood disorders |
| 08/22/2002 | US20020115832 Methods for producing factor VIII proteins |
| 08/22/2002 | US20020115831 Cell surface molecule mediating cell adhesion and signal transmission |
| 08/22/2002 | US20020115830 Detecting modulator of viral activity; for use in treatment of viral diseases |
| 08/22/2002 | US20020115829 Pathogenic escherichia coli associated protein |
| 08/22/2002 | US20020115828 Nucleotide sequences for use in the detection of microorganismal infections |
| 08/22/2002 | US20020115827 Stabilizaton of heat resistant protein; obtain protein, replace aspartic acids with glutamic acids, recover protein |
| 08/22/2002 | US20020115825 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier |
| 08/22/2002 | US20020115631 Human bad polypeptides, encoding nucleic acids and methods of use |
| 08/22/2002 | US20020115627 Phosphatonin-related gene and methods of use thereof |
| 08/22/2002 | US20020115626 Comparing the expression of the nucleic acid encoding an antileuko-protease polypeptide of a cell population to the expression of a nucleic acid encoding the same peptide in an inflammation positive reference profile; enzyme inhibitors |
| 08/22/2002 | US20020115619 Compositions and methods for treatment of cystic fibrosis |
| 08/22/2002 | US20020115612 High-speed automated solid-phase synthesis repeating steps of acylation of a resin-bound secondary amine with haloacetic acid followed by nucleophilic displacement of the halogen by an N-substituted amine; libraries |
| 08/22/2002 | US20020115610 Isolated polypeptides that stimulate gastrointestinal smooth muscle contraction, including human; ionotropic agents; enhanced gastrointestinal motility; identifying a prokineticin receptor ligand; calcium mobilization |
| 08/22/2002 | US20020115608 Uses of transgenic animals containing a type X collagen mutant |
| 08/22/2002 | US20020115607 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); diagnosis, drug screening, animal models |
| 08/22/2002 | US20020115606 Involved in the pathogenesis of Huntington's Disease, Parkinson's Disease, dementia and Alzheimer's Disease (AD); modulating, in a cell, a protein complex between PN7740 and ligand Fe65 or PSD95 |
| 08/22/2002 | US20020115605 Novel peptide with effects on cerebral health |
| 08/22/2002 | US20020115604 HCaRG, a novel calcium-regulated gene coding for a nuclear protein |
| 08/22/2002 | US20020115603 Methods and compositions for the treatment of peripheral artery disease |
| 08/22/2002 | US20020115602 Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide |
| 08/22/2002 | US20020115599 Nucleic acid of given sequence; protein involved in mechanisms during mitosis |
| 08/22/2002 | US20020115592 And optionally aprotinin, in a nonaqueous hydrophilic medium of an alcohol and a cosolvent, in association with a medium chain partial glyceride, optionally in admixture a long-chain polyoxyethylene glycol; fine suspension |
| 08/22/2002 | US20020115591 Gene yneS found in Streptococcus pneumoniae, which is essential for survival for a wide range of bacteria; use to identify antibiotics |
| 08/22/2002 | US20020115220 Plasmid for use as tools in the transformation of candida cells |
| 08/22/2002 | US20020115215 Adjusting chromatin in cells; obtain cells, incubate with fusion proteins, monitor activity of chromosomes |
| 08/22/2002 | US20020115214 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation |
| 08/22/2002 | US20020115212 Cell culture for use in the generation of antitumor agents |
| 08/22/2002 | US20020115209 Animal model for identifying agents that inhibit or enhance CTLA4 signaling |
| 08/22/2002 | US20020115207 Methods and compositions for use in spliceosome mediated RNA trans-splicing |
| 08/22/2002 | US20020115205 Receptor protein for use in the treatment of cancer, infections, psoraisis, asthma, allergies, viral diseases, arteriosclerosis, gland, eye, autoimmune, nervous system and psychological disorders |
| 08/22/2002 | US20020115204 Novel human protease inhibitor proteins and polynucleotides encoding the same |
| 08/22/2002 | US20020115203 Proteins for use in the treatment infectious, cancers and autoimmune disease |
| 08/22/2002 | US20020115202 Adenoviral vectors including dna sequences encoding angiogenic inhibitors |
| 08/22/2002 | US20020115189 Generating genetically engineered, adeno-associated virons: obtain cells, transform with viral vector, express vector, recover transformed cells, culture cells and recover virons |
| 08/22/2002 | US20020115187 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent |
| 08/22/2002 | US20020115185 Nucleotide sequences coding preferential polypeptides for use in the treatment of cancer, nervous system, immunological, autoimmune disorders |
| 08/22/2002 | US20020115184 Antibiotic protein and method of production |
| 08/22/2002 | US20020115181 Enzymatic polypeptide for use in paper making and animal feeds |
| 08/22/2002 | US20020115180 Splicing factor |
| 08/22/2002 | US20020115172 Polypeptides for use in the diagnosis, prevention, and treatment of inflammation, cell proliferation and apoptosis disorders |
| 08/22/2002 | US20020115171 Polypeptides for use in the diagnosis, prevention, and treatment of inflammation, cell proliferation and apoptosis disorders |
| 08/22/2002 | US20020115168 Novel protein zlmda2. |
| 08/22/2002 | US20020115166 Peptide for use in the treatment of pancreatic defects |
| 08/22/2002 | US20020115162 Nucleotide sequences coding for the cysQ gene |
| 08/22/2002 | US20020115159 Nucleotide sequences coding preferential protein for use human medicine, therapeutics, foods and animal nutrients |
| 08/22/2002 | US20020115157 Intrinsically fluorescent, self-multimerizing MHC fusion proteins and complexes thereof |
| 08/22/2002 | US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents |
| 08/22/2002 | US20020115155 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of eating disorders |
| 08/22/2002 | US20020115154 Trail receptors, nucleic acids encoding the same, and methods of use thereof |
| 08/22/2002 | US20020115153 Polypeptide for use in the treatment, diagnosis and prevention of cell proliferation defects and inflammation |
| 08/22/2002 | US20020115152 Expression system for factor VIII |
| 08/22/2002 | US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 08/22/2002 | US20020115150 Polypeptide for use in the treatment and diagnosis of vision defects and diabetes |
| 08/22/2002 | US20020115149 Nucleotide sequences coding membrane protein for use in the treatment of Parkinson's disease, eating disorders, tension and headaches |
| 08/22/2002 | US20020115148 Nucleotide sequences coding polypeptide for use the treatment of skin disorders |
| 08/22/2002 | US20020115145 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/22/2002 | US20020115144 Nucleotide sequences coding protein for use in the diagnosis and treatment of intracellular vessicle defects |
| 08/22/2002 | US20020115142 Tumor associated nucleic acids and uses therefor |
| 08/22/2002 | US20020115141 Method for improved production of cyanophycin and secondary products thereof |
| 08/22/2002 | US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects |
| 08/22/2002 | US20020115139 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of lung tumors |
| 08/22/2002 | US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors |
| 08/22/2002 | US20020115136 Peptide for use in the treatment, diagnosis and prevention of pancreatic disorders and grave's diease |
| 08/22/2002 | US20020115135 Synapse related glycoproteins |
| 08/22/2002 | US20020115119 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020115117 ERbeta-mediated gene expression |
| 08/22/2002 | US20020115112 Neutrokine-alpha and Neutrokine-alpha splice variant |
| 08/22/2002 | US20020115110 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 08/22/2002 | US20020115109 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 08/22/2002 | US20020115104 Detecting antitumor agent; obtain wildtype and mutant proteins, incubate, exposue to modulator, evaluate preferential gene activity |
| 08/22/2002 | US20020115103 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/22/2002 | US20020115102 Novel protein |
| 08/22/2002 | US20020115081 Nucleotide sequences coding polypeptide for use in the the treatament of cardiovasculAR disorders |
| 08/22/2002 | US20020115078 Nucleotide sequences coding polypeptide for use in the treatment and prevention of bacterial infections |
| 08/22/2002 | US20020115075 Polypeptide for use in screening bactericides |